Œsophage

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage

17. Octobre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 3872


	Articles 1 - 20 / 77434

	Retrospective Analysis of CT-based Habitat Analysis for Predicting pCR and Survival of ESCC Treated by Neoadjuvant Chemoradiotherapy and Esophagectomy. Technol Cancer Res Treat Zhang S, Qi WX, Wang F, Zhang Y, Chen J, Zhao S. PMID: 41100689 [PubMed - indexed for MEDLINE]
	Optimizing Proton-pump Inhibitor Therapy in Patients with Comorbidities Receiving Polypharmacy Treatment: Insights from Clinical Practice in India. J Assoc Physicians India Juneja HT, Gambhir S, Junaidy KH. PMID: 41100335 [PubMed - indexed for MEDLINE]
	Application of artificial intelligence in esophageal surgery: a systematic review. J Robot Surg Kröger J, Jorek N, Seitel A, Mayer L, Salg GA, Crnovrsanin N, Pianka F, Pausch T, Maier-Hein L, Michalski C, Nienhüser H. PMID: 41099978 [PubMed - indexed for MEDLINE]
	Acute Radiation Esophagitis After Chemoradiotherapy Demonstrating "Tube-Like" FDG Uptake on PET-CT: Case Report and Literature Review. Cancer Rep (Hoboken) Kawahara T, Ochi N, Matsuzaki K, Kirishi H, Sunada Y, Mimura A, Ichiyama N, Kosaka Y, Nagasaki Y, Nakanishi H, Yamane H, Takigawa N. PMID: 41099317 [PubMed - indexed for MEDLINE]
	Immunotherapy combined with definitive chemoradiotherapy for locally advanced unresectable esophageal squamous cell carcinoma. Front Immunol Hong Y, Tan Q, Li Y, Yang B, Wu Y, Zhao L, Zhao Y, Chen Y, Zhu Z, Zhu X, Gu L, Jiang N. PMID: 41098719 [PubMed - indexed for MEDLINE]
	Exploring the Diagnostic and Predictive Value of Oral Microbiome in Esophageal Cancer: A Systematic Review and Meta-Analysis. Int J Mol Sci Chen JC, Hsu MH, Hu SW, Lin YY. PMID: 41096729 [PubMed - indexed for MEDLINE]
	Brief preoperative frailty predicts postoperative adverse outcomes in older patients with radical esophageal cancer surgery. BMC Geriatr Hao X, Xu Z, Guo Y, Liu J, Tian J, Cao F, Song Y, Liu Y, Fu Q, Cao J, Mi W, Li T. PMID: 41094653 [PubMed - indexed for MEDLINE]
	Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3). BMJ Open Wang X, Li C, Cao Y, Kang X, Leng X, Zheng Y, Zheng B, Guo W, Jing H, Han Y, Chen C, Li Y, Li H. PMID: 41093345 [PubMed - indexed for MEDLINE]
	Impact of staging investigations on nodal upstaging in early esophago-gastric adenocarcinoma: multicenter CONGRESS dataset analysis. Dis Esophagus Cole K, Gossage JA, Bhandari P, Blencowe NS, Chidambaram S, Crosby T, Evans RPT, Griffiths EA, Kamarajah SK, Markar SR, Trudgill N, Underwood TJ, Pucher PH, CONGRESS collaborative. PMID: 41092229 [PubMed - indexed for MEDLINE]
	Real-world outcomes after concurrent chemo-radiotherapy in patients with locally advanced esophageal and gastroesophageal junction cancer. Acta Oncol Mortensen HR, Hoffmann L, Nordsmark M, Thorsen LBJ, Møller DS. PMID: 41090491 [PubMed - indexed for MEDLINE]
	Rare primary malignant melanoma of the esophagus with gastric cardia adenocarcinoma: A case report. Medicine (Baltimore) Zhou Y, Jin LL, Min WW, Shen QB. PMID: 41088653 [PubMed - indexed for MEDLINE]
	Oral microbiota analysis of tongue coating in patients with esophageal adenocarcinoma. Medicine (Baltimore) Wang H, Wang J, Liu J, Shi X, Wang Z, Cao X. PMID: 41088645 [PubMed - indexed for MEDLINE]
	Pathological responses to neoadjuvant immunochemotherapy: implications for survival and recurrence in patients with locally advanced esophageal squamous cell carcinoma. J Transl Med Li Y, Hong Y, Tan Q, Xu Y, Zhou J, Yang B, Xiao G, Huang X, Gu L, Jiang M, Zhao Y, Chen Y, Zhu Z, Zhu X, Wu Y, Jiang N. PMID: 41088460 [PubMed - indexed for MEDLINE]
	Primary Malignant Melanoma of the Oesophagus Treated With Immunotherapy: A Case Report and Scoping Review of the Literature. J Gastrointest Cancer Hopping E, Kennedy L, Barbaro A, Ireland A, Singhal N, Kanhere H. PMID: 41082067 [PubMed - indexed for MEDLINE]
	Adjuvant immunotherapy fails to improve survival in ypStage I esophageal cancer after neoadjuvant immunochemotherapy. Cancer Immunol Immunother Huang Y, Dong F, Fang C, Wu J, Li Z, Chen J, Xie X, Yang H, Luo K, Fu J. PMID: 41081894 [PubMed - indexed for MEDLINE]
	Research Communication: Prevalence of Asymptomatic Premalignant Oesophageal Lesions in Patients With Fanconi Anaemia. Aliment Pharmacol Ther Sloan JA, Wongjarupong N, Christian V, Azeem N, Turner KO, Gyawali CP, MacMillan ML, Wagner JE. PMID: 41081458 [PubMed - indexed for MEDLINE]
	Oropharyngeal microbiome dysbiosis in esophageal squamous cell carcinoma: taxonomic shifts, metabolic reprogramming, and geographic disparities in a high-incidence cohort. PeerJ Liu Y, Wu E, Cheng F, Zhang M, Rou Q, Nuertai Z, Xu M, Xu S, Li M, Zhang L, Nasiroula A. PMID: 41081109 [PubMed - indexed for MEDLINE]
	Health-related quality of life in esophageal cancer: a state-of-the-art review of patient-reported outcomes and an evidence and gap map. Dis Esophagus Färnqvist K, Mälberg K, Johnsson SI, Johar A, Schandl A, Ringborg C, Lagergren P. PMID: 41076644 [PubMed - indexed for MEDLINE]
	Da Vinci-assisted vs laparoscopic nissen fundoplication for GERD: a systematic review and meta-analysis of randomized controlled trials on patient-reported outcomes, dysphagia, and long-term failure. J Robot Surg Mirza W, Khan ME, Uneeb M, Khan HM, Dadan S, Awan AR, Nadeem MA, Chatha HN. PMID: 41075046 [PubMed - indexed for MEDLINE]
	Surimi soft gels for individuals with dysphagia were produced by enzymatic hydrolysis: Investigating the impact on the protein structure and its correlation with gel characteristics. Food Res Int Shi Y, Wang B, Xu Y, Shi Y, Zhu Z. PMID: 41074304 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77434

Page 1 de 3872



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité